BIOA
Price:
$10.5
Market Cap:
$376.48M
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammat...[Read more]
Industry
Biotechnology
IPO Date
2024-09-26
Stock Exchange
NASDAQ
Ticker
BIOA
According to BioAge Labs, Inc.’s latest financial reports and current stock price. The company's current ROE is -25.09%. This represents a change of 297.36% compared to the average of -6.31% of the last 4 quarters.
The mean historical ROE of BioAge Labs, Inc. over the last ten years is 16.70%. The current -25.09% ROE has changed -250.18% with respect to the historical average. Over the past ten years (40 quarters), BIOA's ROE was at its highest in in the December 2023 quarter at 12.09%. The ROE was at its lowest in in the March 2023 quarter at -54.97%.
Average
16.70%
Median
35.29%
Minimum
-22.01%
Maximum
36.83%
Discovering the peaks and valleys of BioAge Labs, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 4.35%
Maximum Annual ROE = 36.83%
Minimum Annual Increase = -159.76%
Minimum Annual ROE = -22.01%
| Year | ROE | Change |
|---|---|---|
| 2024 | -22.01% | -159.76% |
| 2023 | 36.83% | 4.35% |
The current ROE of BioAge Labs, Inc. (BIOA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.70%
5-year avg
16.70%
10-year avg
16.70%
BioAge Labs, Inc.’s ROE is greater than Lifecore Biomedical, Inc. (-253.16%), greater than Canopy Growth Corporation (-98.69%), greater than Allogene Therapeutics, Inc. (-57.79%), greater than Editas Medicine, Inc. (-241.99%), greater than Alpha Teknova, Inc. (-23.53%), less than Aurora Cannabis Inc. (12.55%), greater than Atea Pharmaceuticals, Inc. (-32.55%), greater than Owens & Minor, Inc. (-1259.54%), greater than Cabaletta Bio, Inc. (-107.14%), less than Humacyte, Inc. (449.27%),
| Company | ROE | Market cap |
|---|---|---|
| -253.16% | $290.70M | |
| -98.69% | $290.14M | |
| -57.79% | $323.61M | |
| -241.99% | $206.81M | |
| -23.53% | $258.55M | |
| 12.55% | $258.55M | |
| -32.55% | $241.42M | |
| -1259.54% | $197.02M | |
| -107.14% | $246.44M | |
| 449.27% | $185.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioAge Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioAge Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioAge Labs, Inc.'s ROE?
How is the ROE calculated for BioAge Labs, Inc. (BIOA)?
What is the highest ROE for BioAge Labs, Inc. (BIOA)?
What is the 3-year average ROE for BioAge Labs, Inc. (BIOA)?
What is the 5-year average ROE for BioAge Labs, Inc. (BIOA)?
How does the current ROE for BioAge Labs, Inc. (BIOA) compare to its historical average?